P Drouin

787 total citations
26 papers, 601 citations indexed

About

P Drouin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, P Drouin has authored 26 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Physiology. Recurrent topics in P Drouin's work include Diabetes and associated disorders (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Cancer, Lipids, and Metabolism (3 papers). P Drouin is often cited by papers focused on Diabetes and associated disorders (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Cancer, Lipids, and Metabolism (3 papers). P Drouin collaborates with scholars based in France, United States and Switzerland. P Drouin's co-authors include Bruno Guerci, P. Böhme, Anna Kearney‐Schwartz, Olivier Ziegler, G Debry, Pierre Genton, Mireille Donner, Eric Boerwinkle, Gérard Siest and S. Müller and has published in prestigious journals such as Diabetes Care, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

P Drouin

24 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Drouin France	12	200	190	117	99	94	26	601
Fukashi Ishibashi Japan	16	173 0.9×	183 1.0×	229 2.0×	70 0.7×	110 1.2×	56	810
Norito Yagihashi Japan	14	246 1.2×	136 0.7×	154 1.3×	43 0.4×	113 1.2×	21	678
W Waldhäusl Austria	18	329 1.6×	507 2.7×	145 1.2×	84 0.8×	202 2.1×	48	989
Irena Duka United States	10	304 1.5×	185 1.0×	89 0.8×	245 2.5×	104 1.1×	12	994
Haruhisa Sato Japan	9	205 1.0×	139 0.7×	105 0.9×	79 0.8×	67 0.7×	11	634
Alexei Kouroedov Switzerland	6	220 1.1×	93 0.5×	201 1.7×	136 1.4×	58 0.6×	7	604
Yuichi Hamada Japan	16	236 1.2×	149 0.8×	220 1.9×	49 0.5×	104 1.1×	38	803
Nobuyuki Banba Japan	18	246 1.2×	257 1.4×	248 2.1×	129 1.3×	138 1.5×	35	978
Yoshikuni Fujita Japan	14	159 0.8×	182 1.0×	89 0.8×	54 0.5×	145 1.5×	27	540
Angelika Freudenthaler Austria	13	299 1.5×	98 0.5×	159 1.4×	90 0.9×	79 0.8×	16	703

Countries citing papers authored by P Drouin

Since Specialization

Citations

This map shows the geographic impact of P Drouin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Drouin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Drouin more than expected).

Fields of papers citing papers by P Drouin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Drouin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Drouin. The network helps show where P Drouin may publish in the future.

Co-authorship network of co-authors of P Drouin

This figure shows the co-authorship network connecting the top 25 collaborators of P Drouin. A scholar is included among the top collaborators of P Drouin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Drouin. P Drouin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Minvielle, Stéphane, Olivier Roux, P Drouin, et al.. (2017). Logic programming reveals alteration of key transcription factors in multiple myeloma. Scientific Reports. 7(1). 9257–9257. 18 indexed citations

Guerci, Bruno, et al.. (2001). Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function.. PubMed. 27(4 Pt 1). 425–34. 58 indexed citations

Guerci, Bruno, et al.. (2000). No acute response of leptin to an oral fat load in obese patients and during circadian rhythm in healthy controls. European Journal of Endocrinology. 143(5). 649–655. 15 indexed citations

Muller, S. A., et al.. (1996). Role of Albumin Glycation on the Erythrocyte Aggregation: AnIn Vitro Study. Diabetic Medicine. 13(7). 646–650. 19 indexed citations

Fiévet, Catherine, et al.. (1995). Non-enzymatic glycosylation of apolipoprotein A-I and its functional consequences.. PubMed. 21(2). 95–8. 10 indexed citations

Müller, S., et al.. (1995). Decreased Erythrocyte Membrane Fluidity in Poorly Controlled IDDM: Influence of ketone bodies. Diabetes Care. 18(4). 549–551. 61 indexed citations

Drouin, P. (1992). Le grand communicateur. Population. Vol. 47(6). 1381–1384.

Ziegler, Olivier, et al.. (1992). Erythrocyte aggregation in diabetes mellitus: Role of plasmatic and membrane factors. Clinical Hemorheology and Microcirculation. 12(6). 873–881. 4 indexed citations

Drouin, P. (1992). Le grand communicateur. Population. 47(6). 1381–1381. 1 indexed citations

10.

Visvikis, Sophia, Lawrence Chan, Gérard Siest, P Drouin, & Eric Boerwinkle. (1990). An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Human Genetics. 84(4). 373–5. 51 indexed citations

11.

Ziegler, Olivier, et al.. (1989). Visual Evoked Potentials in Diabetic Patients. Diabetes Care. 12(3). 227–229. 48 indexed citations

12.

Fiévet, Catherine, et al.. (1985). Mapping of lipoprotein particles with monoclonal antibodies in diabetes and atherosclerosis.. PubMed. 13. 134–41.

13.

Villaume, C., et al.. (1984). 28-hour profiles of blood glucose (BG), plasma immunoreactive insulin (IRI) and IRI/BG ratio in four insulinomas.. PubMed. 45(3). 155–60. 8 indexed citations

14.

Drouin, P, et al.. (1983). Comparison of 5 reflectance meters for capillary blood glucose determination.. PubMed. 9(1). 19–25. 2 indexed citations

15.

Drouin, P, et al.. (1983). [Metabolism of lipoproteins].. PubMed. 44(1). 51–8. 5 indexed citations

16.

Lambert, D, et al.. (1983). Modifications in apoprotein C composition of very low density lipoproteins in type IV hyperlipoproteinemic subjects after dietetic triglyceridemia reduction.. PubMed. 41(4). 251–4. 1 indexed citations

17.

Villaume, C., et al.. (1982). Hyperinsulinemia associated with normal C-peptide levels in a woman treated with isoniazide.. PubMed. 36(1). 32–5. 12 indexed citations

18.

Voisin, P., et al.. (1980). [Determination of the level of plasma beta-thromboglobulin in diabetes].. PubMed. 33(6). 194–6. 1 indexed citations

19.

Raffoux, C, et al.. (1978). Type IIa Hyperlipoproteinemia and the HLA System. Tissue Antigens. 11(1). 55–58. 2 indexed citations

20.

Bélanger, Louise & P Drouin. (1966). OSTEOLYSIS IN THE FROG: THE EFFECTS OF PARATHORMONE. Canadian Journal of Physiology and Pharmacology. 44(6). 919–922. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact